Literature DB >> 16472263

How have we been managing chronic obstructive pulmonary disease in Australia?

M C Matheson1, C Abeysena, J M Raven, B Skoric, D P Johns, M J Abramson, E H Walters.   

Abstract

AIM: Although chronic obstructive pulmonary disease (COPD) is a main cause of disability, hospital admissions and premature deaths in Australia, little is known about the community management of COPD in relation to recently published guidelines. The aim of the article was to report on COPD management in a community based cohort.
METHODS: A random sample of adults aged between 45 and 70 years drawn from the electoral roll participated in the study. They completed a detailed respiratory questionnaire, spirometry, methacholine challenge and measurement of transfer factor. COPD was defined according to the Global initiative for Chronic Obstructive Lung Disease (GOLD) criteria. Current asthma was defined as wheeze during the last 12 months together with bronchial hyperreactivity. Subjects were classified as either COPD-only, asthma-only or both asthma and COPD.
RESULTS: Of 1224 subjects completing spirometry, 39 (3.5%) met the GOLD criteria for stage 2 or 3 COPD, asthma-only was found in 99 (8.9%) subjects and 40 (3.6%) subjects had both asthma and COPD. The COPD-only group was significantly older than the other two groups. More than 40% of subjects with COPD did not have a diagnosis of COPD from their doctors. Only 48.7% of subjects with COPD had ever been prescribed medication for their breathing. More than two-thirds of all subjects had seen a doctor for breathing problems, but very few had seen a general practitioner in the last 12 months and even fewer had respiratory function tests.
CONCLUSIONS: Most subjects with COPD are being undertreated. Diagnosis, monitoring and referral systems should be improved. Preventive activities such as influenza vaccination and smoking cessation should be intensified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472263     DOI: 10.1111/j.1445-5994.2006.01011.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  8 in total

1.  Mortality in Western Australian seniors with chronic respiratory diseases: a cohort study.

Authors:  Kristjana Einarsdóttir; David B Preen; Frank M Sanfilippo; Raylene Reeve; Jon D Emery; C D'Arcy J Holman
Journal:  BMC Public Health       Date:  2010-07-01       Impact factor: 3.295

2.  Signs of progress in the Australian post-2000 COPD experience, but some old problems remain.

Authors:  David Dunt; Colleen Doyle
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-06-07

3.  Forecasts of COPD mortality in Australia: 2006-2025.

Authors:  Bircan Erbas; Shahid Ullah; Rob J Hyndman; Michelle Scollo; Michael Abramson
Journal:  BMC Med Res Methodol       Date:  2012-02-21       Impact factor: 4.615

4.  Policy challenges from the "White" Senate inquiry into workplace-related health impacts of toxic dusts and nanoparticles.

Authors:  Thomas A Faunce; Haydn Walters; Trevor Williams; David Bryant; Martin Jennings; Bill Musk
Journal:  Aust New Zealand Health Policy       Date:  2006-06-17

5.  The use of COPD maintenance therapy following spirometry in General Practice.

Authors:  Vibeke Gottlieb; Anne Marie Lyngsø; Ditte Sæbye; Anne Frølich; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2016-06-22

6.  Interdisciplinary model of care (RADICALS) for early detection and management of chronic obstructive pulmonary disease (COPD) in Australian primary care: study protocol for a cluster randomised controlled trial.

Authors:  Jenifer Liang; Michael J Abramson; Nicholas Zwar; Grant Russell; Anne E Holland; Billie Bonevski; Ajay Mahal; Benjamin van Hecke; Kirsten Phillips; Paula Eustace; Eldho Paul; Kate Petrie; Sally Wilson; Johnson George
Journal:  BMJ Open       Date:  2017-09-18       Impact factor: 2.692

7.  A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol.

Authors:  Jeremy M Bunker; Helen K Reddel; Sarah M Dennis; Sandy Middleton; Cp Van Schayck; Alan J Crockett; Iqbal Hasan; Oshana Hermiz; Sanjyot Vagholkar; Guy B Marks; Nicholas A Zwar
Journal:  Implement Sci       Date:  2012-09-07       Impact factor: 7.327

8.  Investigation of barriers to clinical practice guideline-recommended pharmacotherapy in the treatment of COPD.

Authors:  Lea Price; Sarah J Billups; Melissa A Rice; Cynthia Hartsfield
Journal:  Pharm Pract (Granada)       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.